Literature DB >> 323834

The urinary sodium: potassium ratio and response to diuretics in resistant oedema.

W D Alexander, R A Branch, D F Levine, M Hartog.   

Abstract

Nineteen patients with severe oedema due to either cirrhosis of the liver or to congestive cardiac failure, who had failed to respond to previous diuretic therapy, were treated with either increasing doses of frusemide (Group A), or with frusemide in a fixed dose of 80 mg daily and increasing doses of spironolactone (Group B). In Group A there was an inverse correlation between the baseline 24-hr urinary sodium: potassium (Na : K) ratio and the 24-hr urinary potassium excretion during diuresis, and a direct correlation between the urinary Na : K ratio before and after diuresis. Thus, in patients of this group during diuresis, there was a significantly higher urinary potassium excretion in those with a baseline urinary Na : K ratio of less than 1, as compared with those with a ratio of greater than 1. In Group B a satisfactory diuresis was achieved without marked urinary potassium loss in those patients with a baseline urinary Na : K ratio of less than 1, whereas no diuresis was obtained in the two patients with a baseline urinary Na : K ratio of greater than 1. These results suggest that the measurement of the baseline urinary Na : K ratio is of help in determining the potential value of spironolactone in patients with resistant oedema.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 323834      PMCID: PMC2496468          DOI: 10.1136/pgmj.53.617.117

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  11 in total

1.  A CLINICAL TRIAL OF FRUSEMIDE.

Authors:  D VEREL; N H STENTIFORD; F RAHMAN; R SAYNOR
Journal:  Lancet       Date:  1964-11-21       Impact factor: 79.321

2.  CARDIAC FAILURE AND HORMONAL CONTROL OF FLUID AND ELECTROLYTE BALANCE.

Authors:  F C BARTTER
Journal:  Surg Gynecol Obstet       Date:  1964-04

3.  ALDOSTERONE AND THE EDEMA OF CONGESTIVE HEART FAILURE.

Authors:  L L SANDERS; J C MELBY
Journal:  Arch Intern Med       Date:  1964-03

4.  Relation between diuretic agents and aldosterone in cardiac and cirrhotic patients with sodium retention.

Authors:  J P THOMAS; F C BARTTER
Journal:  Br Med J       Date:  1961-04-22

5.  The effects of intravenous aldosterone and hydrocortisone on the urinary electrolytes of the recumbent human subject.

Authors:  J N MILLS; S THOMAS; K S WILLIAMSON
Journal:  J Physiol       Date:  1961-05       Impact factor: 5.182

6.  The action of hydroflumethiazide in relation to adrenal steroids and potassium loss.

Authors:  C J EDMONDS; G M WILSON
Journal:  Lancet       Date:  1960-03-05       Impact factor: 79.321

7.  An aldosterone antagonist and diuretics in the treatment of chronic oedema and ascites.

Authors:  C J EDMONDS
Journal:  Lancet       Date:  1960-03-05       Impact factor: 79.321

8.  Neuropsychiatric complications following chlorothiazide therapy in patients with hepatic cirrhosis: possible relation to hypokalaemia.

Authors:  A E READ; J LAIDLAW; R M HASLAM; S SHERLOCK
Journal:  Clin Sci       Date:  1959-08       Impact factor: 6.124

9.  Urinary excretion of sodium and potassium in relation to plasma aldosterone concentration.

Authors:  A R Adamson; S W Jamieson
Journal:  J Endocrinol       Date:  1972-06       Impact factor: 4.286

10.  Furosemide. A clinical evaluation of its diuretic action.

Authors:  W B Stason; P J Cannon; H O Heinemann; J H Laragh
Journal:  Circulation       Date:  1966-11       Impact factor: 29.690

View more
  9 in total

1.  Interaction between irbesartan, peroxisome proliferator-activated receptor (PPAR-γ), and adiponectin in the regulation of blood pressure and renal function in spontaneously hypertensive rats.

Authors:  S Afzal; M A Sattar; Edward J Johns; Mohammed H Abdulla; Safia Akhtar; Fayyaz Hashmi; Nor Azizan Abdullah
Journal:  J Physiol Biochem       Date:  2016-07-12       Impact factor: 4.158

Review 2.  Clinical pharmacokinetics of frusemide.

Authors:  R E Cutler; A D Blair
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

Review 3.  Pharmacokinetics of loop diuretics in congestive heart failure.

Authors:  D C Brater
Journal:  Br Heart J       Date:  1994-08

4.  The Diuretic Effects of Coconut Water by Suppressing Aquaporin and Renin-Angiotensin-Aldosterone System in Saline-Loaded Rats.

Authors:  Jing Wei; Mantong Zhao; Keke Meng; Guanghua Xia; Yonggui Pan; Congfa Li; Weimin Zhang
Journal:  Front Nutr       Date:  2022-06-23

5.  Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect.

Authors:  João Pedro Ferreira; Nicolas Girerd; Pedro Bettencourt Medeiros; Mário Santos; Henrique Cyrne Carvalho; Paulo Bettencourt; David Kénizou; Javed Butler; Faiez Zannad; Patrick Rossignol
Journal:  Clin Res Cardiol       Date:  2015-11-28       Impact factor: 5.460

6.  Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide.

Authors:  E Keller; G Hoppe-Seyler; R Mumm; P Schollmeyer
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

7.  Diuretic activity of the aqueous crude extract and solvent fractions of the leaves of Thymus serrulatus in mice.

Authors:  Amelework Eshetu Melka; Eyasu Makonnen; Asfaw Debella; Netsanet Fekadu; Bekesho Geleta
Journal:  J Exp Pharmacol       Date:  2016-10-31

8.  In Vivo Diuretic Activity of Hydromethanolic Extract and Solvent Fractions of the Root Bark of Clerodendrum myricoides Hochst. (Lamiaceae).

Authors:  Gebrelibanos Gebremichael Welu; Ebrahim M Yimer; Haftom Gebregergs Hailu; Dayananda Bhoumik; Mehari Meles Lema
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-10       Impact factor: 2.629

9.  Renoprotective and haemodynamic effects of adiponectin and peroxisome proliferator-activated receptor agonist, pioglitazone, in renal vasculature of diabetic Spontaneously hypertensive rats.

Authors:  Sheryar Afzal; Munavvar Abdul Sattar; Edward James Johns; Olorunfemi A Eseyin
Journal:  PLoS One       Date:  2020-11-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.